advertisement
Nakamura M 15
Showing records 1 to 15 | Display all abstracts from Nakamura M84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Mori S
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Murai Y
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Ueda K; Sakamoto M
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Kurimoto T
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shimazaki A
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Yamada-Nakanishi Y
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Nakamura M
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Yamada-Nakanishi Y
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shiga Y
Scientific reports 2019; 9: 19288
85204 A comparison of the 1-year surgical outcomes of trabeculotomy and microhook trabeculotomy using propensity score analysis
Nakamura M
BMJ open ophthalmology 2020; 5: e000446
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Tsuda S; Omodaka K; Saya H; Nakazawa T
Scientific reports 2019; 9: 19288
